• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

经皮机械循环支持装置在急性心肌梗死并发心源性休克及高危经皮冠状动脉介入治疗中的应用

Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary Interventions.

作者信息

Asleh Rabea, Resar Jon R

机构信息

Division of Cardiology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA.

出版信息

J Clin Med. 2019 Aug 13;8(8):1209. doi: 10.3390/jcm8081209.

DOI:10.3390/jcm8081209
PMID:31412669
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6724052/
Abstract

Given the tremendous progress in interventional cardiology over the last decade, a growing number of older patients, who have more comorbidities and more complex coronary artery disease, are being considered for technically challenging and high-risk percutaneous coronary interventions (PCI). The success of performing such complex PCI is increasingly dependent on the availability and improvement of mechanical circulatory support (MCS) devices, which aim to provide hemodynamic support and left ventricular (LV) unloading to enable safe and successful coronary revascularization. MCS as an adjunct to high-risk PCI may, therefore, be an important component for improvement in clinical outcomes. MCS devices in this setting can be used for two main clinical conditions: patients who present with cardiogenic shock complicating acute myocardial infarction (AMI) and those undergoing technically complex and high-risk PCI without having overt cardiogenic shock. The current article reviews the advancement in the use of various devices in both AMI complicated by cardiogenic shock and complex high-risk PCI, highlights the available hemodynamic and clinical data associated with the use of MCS devices, and presents suggestive management strategies focusing on appropriate patient selection and optimal timing and support to potentially increase the clinical benefit from utilizing these devices during PCI in this high-risk group of patients.

摘要

鉴于过去十年间介入心脏病学取得了巨大进展,越来越多合并症更多、冠状动脉疾病更复杂的老年患者正在考虑接受技术难度大且风险高的经皮冠状动脉介入治疗(PCI)。实施此类复杂PCI的成功越来越依赖于机械循环支持(MCS)设备的可用性和改进,这些设备旨在提供血流动力学支持和左心室(LV)减负,以实现安全且成功的冠状动脉血运重建。因此,MCS作为高危PCI的辅助手段,可能是改善临床结局的重要组成部分。在此背景下,MCS设备可用于两种主要临床情况:出现心源性休克并发急性心肌梗死(AMI)的患者,以及接受技术复杂且高危PCI但无明显心源性休克的患者。本文综述了在AMI并发心源性休克和复杂高危PCI中使用各种设备的进展,强调了与使用MCS设备相关的可用血流动力学和临床数据,并提出了针对性的管理策略,重点在于适当的患者选择、最佳时机和支持,以潜在增加在这一高危患者群体的PCI过程中使用这些设备的临床获益。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40ff/6724052/6890511e275d/jcm-08-01209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40ff/6724052/2091d5c13871/jcm-08-01209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40ff/6724052/6890511e275d/jcm-08-01209-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40ff/6724052/2091d5c13871/jcm-08-01209-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/40ff/6724052/6890511e275d/jcm-08-01209-g002.jpg

相似文献

1
Utilization of Percutaneous Mechanical Circulatory Support Devices in Cardiogenic Shock Complicating Acute Myocardial Infarction and High-Risk Percutaneous Coronary Interventions.经皮机械循环支持装置在急性心肌梗死并发心源性休克及高危经皮冠状动脉介入治疗中的应用
J Clin Med. 2019 Aug 13;8(8):1209. doi: 10.3390/jcm8081209.
2
Use of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.急性心肌梗死合并心源性休克患者使用机械循环支持装置的情况
JAMA Netw Open. 2021 Feb 1;4(2):e2037748. doi: 10.1001/jamanetworkopen.2020.37748.
3
Association of Use of an Intravascular Microaxial Left Ventricular Assist Device vs Intra-aortic Balloon Pump With In-Hospital Mortality and Major Bleeding Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.血管内微型轴流左心室辅助装置与主动脉内球囊泵在急性心肌梗死合并心源性休克患者中的应用与院内死亡率和大出血的关系。
JAMA. 2020 Feb 25;323(8):734-745. doi: 10.1001/jama.2020.0254.
4
Mechanical circulatory support versus vasopressors alone in patients with acute myocardial infarction and cardiogenic shock undergoing percutaneous coronary intervention.机械循环支持与单独使用血管加压素在接受经皮冠状动脉介入治疗的急性心肌梗死合并心原性休克患者中的比较。
Catheter Cardiovasc Interv. 2024 Jan;103(1):30-41. doi: 10.1002/ccd.30913. Epub 2023 Nov 23.
5
Current clinical management of acute myocardial infarction complicated by cardiogenic shock.急性心肌梗死合并心原性休克的临床处理现状。
Expert Rev Cardiovasc Ther. 2021 Jan;19(1):41-46. doi: 10.1080/14779072.2021.1854733. Epub 2021 Jan 19.
6
Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.急性心肌梗合并需要静脉动脉体外膜肺氧合的晚期心源性休克患者中,罪犯血管血运重建与即刻多血管经皮冠状动脉介入治疗的比较。
J Am Heart Assoc. 2023 May 16;12(10):e029792. doi: 10.1161/JAHA.123.029792. Epub 2023 May 9.
7
Hemodynamic Support Devices for Shock and High-Risk PCI: When and Which One.用于休克和高危经皮冠状动脉介入治疗的血流动力学支持装置:何时使用及选用哪种
Curr Cardiol Rep. 2017 Aug 31;19(10):100. doi: 10.1007/s11886-017-0905-3.
8
[Reperfusion therapy and mechanical circulatory support in patients in cardiogenic shock].[心源性休克患者的再灌注治疗与机械循环支持]
Herz. 1999 Oct;24(6):448-64. doi: 10.1007/BF03044431.
9
Early Impella Support in Postcardiac Arrest Cardiogenic Shock Complicating Acute Myocardial Infarction Improves Short- and Long-Term Survival.早期经皮 Impella 辅助治疗急性心肌梗死后并发心原性休克伴心脏骤停可改善短期和长期生存率。
Crit Care Med. 2021 Jun 1;49(6):943-955. doi: 10.1097/CCM.0000000000004915.
10
Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.多支血管病变与罪犯病变血运重建治疗并发急性心肌梗死后心原性休克:系统评价和荟萃分析。
Eur Heart J Acute Cardiovasc Care. 2018 Feb;7(1):28-37. doi: 10.1177/2048872617719640. Epub 2017 Jul 13.

引用本文的文献

1
Acute myocardial infarction with ventricular septal rupture: Clinical characteristics, prognosis factors, and treatment strategies.急性心肌梗死合并室间隔破裂:临床特征、预后因素及治疗策略
World J Cardiol. 2025 Jul 26;17(7):109787. doi: 10.4330/wjc.v17.i7.109787.
2
Feasibility and Effectiveness of Venoarterial Extracorporeal Membrane Oxygenation Plus Intra-Aortic Balloon Pump Assisted High-Risk Percutaneous Coronary Intervention in Complex Coronary Disease.静脉-动脉体外膜肺氧合联合主动脉内球囊反搏辅助高危经皮冠状动脉介入治疗复杂冠心病的可行性和有效性
Acta Cardiol Sin. 2024 Sep;40(5):577-584. doi: 10.6515/ACS.202409_40(5).20240617F.
3

本文引用的文献

1
A comprehensive review of randomized clinical trials in three medical journals reveals 396 medical reversals.对三家医学期刊的随机临床试验进行综合回顾,发现有 396 项医学研究结果发生了逆转。
Elife. 2019 Jun 11;8:e45183. doi: 10.7554/eLife.45183.
2
Rationale and design of DanGer shock: Danish-German cardiogenic shock trial.背景和设计:丹麦-德国心原性休克试验(DanGer 休克试验)。
Am Heart J. 2019 Aug;214:60-68. doi: 10.1016/j.ahj.2019.04.019. Epub 2019 May 6.
3
Cardiac Arrest Prior to Venoarterial Extracorporeal Membrane Oxygenation: Risk Factors for Mortality.
Review of Advancements in Managing Cardiogenic Shock: From Emergency Care Protocols to Long-Term Therapeutic Strategies.
心源性休克管理进展综述:从急救方案到长期治疗策略
J Clin Med. 2024 Aug 16;13(16):4841. doi: 10.3390/jcm13164841.
4
Contemporary Left Main Percutaneous Coronary Intervention: A State-of-the-art Review.当代左主干经皮冠状动脉介入治疗:最新综述
Interv Cardiol. 2023 May 26;18:e20. doi: 10.15420/icr.2023.02. eCollection 2023.
5
The Use of Cardioprotective Devices and Strategies in Patients Undergoing Percutaneous Procedures and Cardiac Surgery.经皮手术和心脏手术患者中心脏保护装置和策略的应用
Healthcare (Basel). 2023 Apr 11;11(8):1094. doi: 10.3390/healthcare11081094.
6
Long-term clinical outcomes in patients with acute myocardial infarction complicated by cardiogenic shock according to the application and initiation time of extracorporeal membrane oxygenation in South Korea.根据韩国体外膜肺氧合应用和启动时间,急性心肌梗死合并心原性休克患者的长期临床结局。
Cardiol J. 2023;30(5):713-724. doi: 10.5603/CJ.a2022.0101. Epub 2022 Nov 7.
7
Developing a Time-Adaptive Prediction Model for Out-of-Hospital Cardiac Arrest: Nationwide Cohort Study in Korea.开发院外心脏骤停的时间自适应预测模型:韩国全国队列研究。
J Med Internet Res. 2021 Jul 5;23(7):e28361. doi: 10.2196/28361.
8
Long-term outcomes of high-risk percutaneous coronary interventions under extracorporeal membrane oxygenation support: An observational study.体外膜肺氧合支持下高危经皮冠状动脉介入治疗的长期结局:一项观察性研究。
World J Clin Cases. 2022 Jun 6;10(16):5266-5274. doi: 10.12998/wjcc.v10.i16.5266.
9
Radiographic assessment of lung edema (RALE) score is associated with clinical outcomes in patients with refractory cardiogenic shock and refractory cardiac arrest after percutaneous implantation of extracorporeal life support.体外生命支持经皮植入后难治性心源性休克和难治性心脏骤停患者肺水肿(RALE)评分与临床结局相关的放射评估。
Intern Emerg Med. 2022 Aug;17(5):1463-1470. doi: 10.1007/s11739-022-02937-7. Epub 2022 Feb 15.
10
Complicating Acute Myocardial Infarction. Current Status and Unresolved Targets for Subsequent Research.急性心肌梗死的并发症。当前状况及后续研究的未解决目标
J Clin Med. 2021 Dec 16;10(24):5904. doi: 10.3390/jcm10245904.
心肺复苏前应用体外膜肺氧合治疗的危险因素:死亡率。
Crit Care Med. 2019 Jul;47(7):926-933. doi: 10.1097/CCM.0000000000003772.
4
Real-world clinical experience with the percutaneous extracorporeal life support system: Results from the German Lifebridge Registry.真实世界中经皮体外生命支持系统的临床应用经验:来自德国生命桥注册研究的数据。
Clin Res Cardiol. 2020 Jan;109(1):46-53. doi: 10.1007/s00392-019-01482-2. Epub 2019 Apr 26.
5
Improved Outcomes Associated with the use of Shock Protocols: Updates from the National Cardiogenic Shock Initiative.休克方案的应用与改善预后相关:国家心源性休克倡议的最新进展。
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1173-1183. doi: 10.1002/ccd.28307. Epub 2019 Apr 25.
6
Percutaneous Coronary Intervention in Older Patients With ST-Segment Elevation Myocardial Infarction and Cardiogenic Shock.老年 ST 段抬高型心肌梗死合并心原性休克患者的经皮冠状动脉介入治疗。
J Am Coll Cardiol. 2019 Apr 23;73(15):1890-1900. doi: 10.1016/j.jacc.2019.01.055.
7
Reply: Does VA-ECMO Plus Impella Work in Refractory Cardiogenic Shock?回复:VA-ECMO联合Impella在难治性心源性休克中是否有效?
JACC Heart Fail. 2019 Apr;7(4):364-365. doi: 10.1016/j.jchf.2019.01.001.
8
Mechanical circulatory support with Impella versus intra-aortic balloon pump or medical treatment in cardiogenic shock-a critical appraisal of current data.机械循环支持与 Impella 与主动脉内球囊泵或药物治疗在心源性休克中的比较-对当前数据的批判性评价。
Clin Res Cardiol. 2019 Nov;108(11):1249-1257. doi: 10.1007/s00392-019-01458-2. Epub 2019 Mar 21.
9
Lactate Clearance Predicts Good Neurological Outcomes in Cardiac Arrest Patients Treated with Extracorporeal Cardiopulmonary Resuscitation.乳酸清除率可预测接受体外心肺复苏治疗的心脏骤停患者的良好神经功能结局。
J Clin Med. 2019 Mar 18;8(3):374. doi: 10.3390/jcm8030374.
10
Left Ventricular Unloading During Extracorporeal Membrane Oxygenation in Patients With Cardiogenic Shock.体外膜肺氧合治疗心原性休克患者时的左心室卸载。
J Am Coll Cardiol. 2019 Feb 19;73(6):654-662. doi: 10.1016/j.jacc.2018.10.085.